Rockwell Medical Buys Hemodialysis Concentrates Business From Evoqua Water Technologies For $11M Up Front Cash Plus Two Milestone Payments
Portfolio Pulse from Benzinga Newsdesk
Rockwell Medical has acquired the hemodialysis concentrates business from Evoqua Water Technologies for $11M upfront cash plus two milestone payments. The deal includes all contracts, intellectual property, FDA 510(k) clearances, and assets related to Evoqua's concentrates business.
July 11, 2023 | 10:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rockwell Medical's acquisition of Evoqua's concentrates business could potentially strengthen its position in the healthcare sector, particularly in hemodialysis.
The acquisition of Evoqua's concentrates business, which includes all contracts, intellectual property, FDA 510(k) clearances, and assets, could potentially enhance Rockwell Medical's product portfolio and strengthen its position in the healthcare sector, particularly in hemodialysis. This could have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100